Xarelto on Prevention of Stroke and Noncentral Nervous System Systemic Embolism in Treatment Naïve Asian Patients With Non-valvular Atrial Fibrillation "XaMINA"

Recruiting

Phase N/A Results N/A

Summary of Purpose

The purpose of the study is to collect additional information of Xarelto treatment in routine clinical practice. Patients affected by atrial fibrillation and who will get Xarelto as a prophylactic treatment against stroke and systemic embolism (Stroke Prevention in Atrial Fibrillation) will be observed.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 13 November 2017.

11 Sep 2017 14 Sep 2017 30 Sep 2019 30 Sep 2019 1 Nov 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

Not available

Contacts